SI-BONE, Inc. Files 8-K with Financial Updates
Ticker: SIBN · Form: 8-K · Filed: 2024-05-06T00:00:00.000Z
Sentiment: neutral
Topics: financial-reporting, 8-K, operations
Related Tickers: SIBN
TL;DR
SI-BONE dropped an 8-K on May 6th with financial results and exhibits. Check it out.
AI Summary
On May 6, 2024, SI-BONE, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits, providing an update on the company's performance. SI-BONE, Inc. is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus industry.
Why It Matters
This filing provides investors with crucial, up-to-date financial information and operational details for SI-BONE, Inc., enabling informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting financial information and exhibits, which typically carries a low risk of immediate market impact.
Key Players & Entities
- SI-BONE, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- May 6, 2024 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for SI-BONE, Inc.?
The primary purpose is to report on the company's Results of Operations and Financial Condition, along with providing Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on May 6, 2024.
What is SI-BONE, Inc.'s Standard Industrial Classification code?
SI-BONE, Inc.'s Standard Industrial Classification code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
In which state is SI-BONE, Inc. incorporated?
SI-BONE, Inc. is incorporated in Delaware.
What is the Commission File Number for SI-BONE, Inc.'s 8-K filing?
The Commission File Number for SI-BONE, Inc.'s 8-K filing is 001-38701.
Filing Stats: 528 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-05-06 16:10:10
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share SIBN The Nasdaq Global Market
Filing Documents
- sibn-20240506.htm (8-K) — 30KB
- exhibit991_sibn3312024earn.htm (EX-99.1) — 93KB
- si-bonelogoa07a.jpg (GRAPHIC) — 31KB
- 0001459839-24-000039.txt ( ) — 289KB
- sibn-20240506.xsd (EX-101.SCH) — 2KB
- sibn-20240506_lab.xml (EX-101.LAB) — 21KB
- sibn-20240506_pre.xml (EX-101.PRE) — 12KB
- sibn-20240506_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On May 6, 2024, SI-BONE, Inc. (the "Company") issued a press release (the "Press Release") announcing results for the quarter ended March 31, 2024. A copy of the Press Release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein. The information under Item 2.02 in this current report on Form 8-K and the related information in the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated May 6, 2024 104 Cover Page Interactive Date File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SI-BONE, INC. Date: May 6, 2024 By: /s/ Anshul Maheshwari Anshul Maheshwari Chief Financial Officer (Principal Financial and Accounting Officer)